Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
353.42
+9.86 (2.87%)
May 26, 2026, 12:49 PM EDT - Market open
PRAX Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
168
Market Cap
9.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 8.55M | 6.11M | 249.53% |
| Dec 31, 2023 | 2.45M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioMarin Pharmaceutical | 3.24B |
| Halozyme Therapeutics | 1.51B |
| Bio-Techne | 1.21B |
| Madrigal Pharmaceuticals | 1.13B |
| Axsome Therapeutics | 708.24M |
| Arrowhead Pharmaceuticals | 622.01M |
| Krystal Biotech | 417.30M |
| ImmunityBio | 140.98M |
PRAX News
- 13 days ago - Praxis Precision assumed with a Buy at Truist - TheFly
- 13 days ago - Praxis Precision Medicines Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Praxis Precision Medicines Q1 Earnings Call Highlights - MarketBeat
- 18 days ago - Praxis Precision price target lowered to $420 from $444 at Deutsche Bank - TheFly
- 18 days ago - Praxis Precision price target raised to $166 from $130 at Wedbush - TheFly
- 19 days ago - Praxis Precision Medicines Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - Praxis Precision Medicines Earnings release: Q1 2026 - Filings
- 19 days ago - Praxis Precision Medicines Quarterly report: Q1 2026 - Filings